DIA 2017 Annual Meeting has ended

Create Your Own Event

DIA 2017 Annual Meeting

11:00am CDT

#106: Leveraging Big Data/ Real-World Data in Enabling Efficient and Data-Driven Clinical Research From Sponsor, Vendor and National Health System Perspective: Case Studies N229 #108: Artificial Intelligence/Machine Learning S502ab #113: We Can't Forget the Children in This Process N426c #123: Calling All Angels to the Valley of Death S405b #124: Exploration of PK/PD in NDA Enabling or Early Proof of Concept Studies S402ab

10:30am CDT

#220: Cardiac Safety S401bc #219: Safety Evaluation: Transforming Information into Evidence S401a #223: Introduction to Rare Disease Studies: Challenges of Rare Disease From a Statistical, Protocol Development, and Operations Perspective S503ab #224: Success in Early CNS Drug Development: Getting Proof-of-Principle by Stacking the Deck with Biomarkers S504abc #228: Master Protocols: New Approaches to Enrolling Hard-to-Find Subjects and Expediting Drug Development S405a #229: Outcomes Standardization: An Imperative to Value Assessments N426c

2:00pm CDT

#244: New Trial Design Approaches: Including New Endpoints S501abc #256: Post-Trial Access: Ensuring Patient Access Across the Development Spectrum N230b #258: Patient-Reported Outcomes (PROs): Hot Topics - Part 1 of 2 S404d #259: Novel Techniques for Improving Clinical Trial Subject Retention S405a

4:00pm CDT

#272: Microbiome: Innovative Therapeutics, Challenges, and Opportunities S502ab #286: Audits and Agency Inspections of Risk-Based Monitored Studies: The Results Are In... S405b #269: Big Data: Genomics and Personalized Medicine N226 #282: Challenges and Issues in Early-Phase Oncology Trials S504abc #283: The Impact of Industry Consortia on Creating Collaborative Solutions to Drug Development Challenges: What Does the Future Hold? N426b #284: Use of Novel Trial Designs to Accelerate Decision Making: To 'P' No More S401a #285: What Question Are You Trying to Answer? The Use of Estimands, Potential Revisions to ICH E-9 and the Impact to Trial Design and Analysis S405a #287: Patient-Reported Outcomes (PROs): Hot Topics - Part 2 of 2 S404d

10:30am CDT

#309: Big Data: Combining Registries and Legacy Clinical Trial Databases S505ab #310: New Site Paradigm: Just in Time Sites N229 #312: CRISPR: Regulatory Challenges in the Gene Editing Revolution N228 #317: Evolution of Novel Registration Endpoints as Diseases Become Chronic S404bc #322: Is the Future Bright for Treatment of Neurodegenerative Diseases? S504abc #326: Optimizing Early Clinical Strategies to Support Breakthrough Therapy Designation S401a

2:00pm CDT

#357: Biosimilars and Generics: Access Versus Innovation S405b #345: Global Perspective on ICH: Part 1 of 2 N228 #350: Innovative Designs and Statistical Approaches for Small Trials: Rare Disease or Pediatric Indications S502ab #353: What Do the Experts Believe? Translating Expert Knowledge and Judgment Into a Quantitative Belief Distribution S401bc #354: Experimental Studies: New Approaches to Study Designs to Facilitate Early Phase Decision Making S405a #356: Value-Based Conversations with Payers: Issues, Opportunities, and Barriers S503ab

4:00pm CDT

#365: Next Generation Predictive Analytics S503ab #374: Global Perspective on ICH: Part 2 of 2 N228 #381: Maximizing Success in Partner Collaborations N426b #383: Safety Issues in First-in-Human Studies S405b #384: The Increasing Role for Big Data for Late Phase Drug and Postapproval Purposes S401a

10:45am CDT

#411: Evolving Clinical Trial Guidance and Regulations: Am I Ready? S405b #402: Online Patient Networking S404a #406: Recruiting Rare Disease Patients: A Unique Set of Challenges S401a #407: Exploration of Metabolic Diseases: Is the Liver the New Heart? S401d #408: Flexing Your Project Management Muscles Outside of Traditional Roles S404d #410: Of Course My Data Has Integrity … And I Can Prove It S405a